Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein-Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation

被引:3
|
作者
Xu, Yijie [1 ,2 ]
Zeng, Chunlan [2 ]
Wen, Huiqi [3 ]
Shi, Qianqian [1 ,2 ]
Zhao, Xu [4 ]
Meng, Qingbin [2 ]
Li, Xingzhou [1 ,2 ]
Xiao, Junhai [1 ,2 ]
机构
[1] Beijing Inst Pharmacol & Toxicol, Natl Engn Res Ctr Strateg Drugs, Beijing 100850, Peoples R China
[2] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing 100850, Peoples R China
[3] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Hepatol, Beijing 100039, Peoples R China
关键词
AI-2; quorum sensing; antibacterial agents; LsrK; virtual screening; molecular dynamics; quorum sensing inhibitors; HPr; SALMONELLA-TYPHIMURIUM; SIGNAL; COMMUNICATION; FAMILY; PHOSPHORYLATION; EXPRESSION; LASR; AL-2; HPR;
D O I
10.3390/ph16050737
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Quorum sensing (QS) is a cell-to-cell communication mechanism that regulates bacterial pathogenicity, biofilm formation, and antibiotic sensitivity. Among the identified quorum sensing, AI-2 QS exists in both Gram-negative and Gram-positive bacteria and is responsible for interspecies communication. Recent studies have highlighted the connection between the phosphotransferase system (PTS) and AI-2 QS, with this link being associated with protein-protein interaction (PPI) between HPr and LsrK. Here, we first discovered several AI-2 QSIs targeting the LsrK/HPr PPI site through molecular dynamics (MD) simulation, virtual screening, and bioassay evaluation. Of the 62 compounds purchased, eight compounds demonstrated significant inhibition in LsrK-based assays and AI-2 QS interference assays. Surface plasmon resonance (SPR) analysis confirmed that the hit compound 4171-0375 specifically bound to the LsrK-N protein (HPr binding domain, KD = 2.51 x 10(-5) M), and therefore the LsrK/HPr PPI site. The structure-activity relationships (SARs) emphasized the importance of hydrophobic interactions with the hydrophobic pocket and hydrogen bonds or salt bridges with key residues of LsrK for LsrK/HPr PPI inhibitors. These new AI-2 QSIs, especially 4171-0375, exhibited novel structures, significant LsrK inhibition, and were suitable for structural modification to search for more effective AI-2 QSIs.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Virtual screening and molecular dynamics simulation study of abyssomicins as potential inhibitors of COVID-19 virus main protease and spike protein
    Al-Wahaibi, Lamya H.
    Rehman, Md Tabish
    Al-Saleem, Muneera S. M.
    Basudan, Omer A.
    El-Gamal, Ali A.
    Abdelkader, Mohamed S. A.
    AlAjmi, Mohamed F.
    Abdel-Mageed, Wael M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (18): : 8961 - 8977
  • [42] Discovery of potential inhibitors targeting the kinase domain of polynucleotide kinase/phosphatase (PNKP): Homology modeling, virtual screening based on multiple conformations, and molecular dynamics simulation
    Zhu, Jingyu
    Zhang, Haoer
    Jia, Lei
    Ma, Lijun
    Xu, Lei
    Chen, Yun
    Cai, Yanfei
    Li, Huazhong
    Huang, Gang
    Jin, Jian
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 94 (94)
  • [43] Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity
    Teotia, Vineeta
    Jha, Prakash
    Chopra, Madhu
    ACS OMEGA, 2024, 9 (38): : 39873 - 39892
  • [44] Identification of Novel Inhibitors Targeting SGK1 via Ensemble-Based Virtual Screening Method, Biological Evaluation and Molecular Dynamics Simulation
    Zhang, Hui
    Shen, Chen
    Zhang, Hong-Rui
    Qi, Hua-Zhao
    Hu, Mei-Ling
    Luo, Qing-Qing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [45] A virtual-system coupled multicanonical molecular dynamics simulation: Principles and applications to free-energy landscape of protein-protein interaction with an all-atom model in explicit solvent
    Higo, Junichi
    Umezawa, Koji
    Nakamura, Haruki
    JOURNAL OF CHEMICAL PHYSICS, 2013, 138 (18):
  • [46] Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
    Prajapat, Manisha
    Shekhar, Nishant
    Sarma, Phulen
    Avti, Pramod
    Singh, Sanjay
    Kaur, Hardeep
    Bhattacharyya, Anusuya
    Kumar, Subodh
    Sharma, Saurabh
    Prakash, Ajay
    Medhi, Bikash
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 101
  • [47] A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides
    Lu, Meng-Chen
    Yuan, Zhen-Wei
    Jiang, Yong-Lin
    Chen, Zhi-Yun
    You, Qi-Dong
    Jiang, Zheng-Yu
    MOLECULAR BIOSYSTEMS, 2016, 12 (04) : 1378 - 1387
  • [48] Fluorophenols bearing nitrogenated heterocycle moieties, a class of novel Keap1-Nrf2 protein-protein interaction inhibitors: synthesis, antioxidant stress screening and molecular docking
    Feng, Xiu E.
    Kong, De Peng
    Ban, Shu Rong
    Ge, Rui
    Li, Qing Shan
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (08) : 1319 - 1337
  • [49] Fluorophenols bearing nitrogenated heterocycle moieties, a class of novel Keap1-Nrf2 protein-protein interaction inhibitors: synthesis, antioxidant stress screening and molecular docking
    Xiu E Feng
    De Peng Kong
    Shu Rong Ban
    Rui Ge
    Qing Shan Li
    Medicinal Chemistry Research, 2019, 28 : 1319 - 1337
  • [50] Discovery of Ubiquitin-Specific Protease 7 (USP7) Inhibitors with Novel Scaffold Structures by Virtual Screening, Molecular Dynamics Simulation, and Biological Evaluation
    Liu, Shengjie
    Zhou, Xinyu
    Li, Minglei
    Zhao, Wenfeng
    Zhou, Shuxi
    Cheng, Keguang
    Xu, Qinglong
    Chen, Caiping
    Wen, Xiaoan
    Sun, Hongbin
    Yuan, Haoliang
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (06) : 3255 - 3264